It’s a quick one today because I’m at the Tufts CEVR annual meeting, and that’s not something that can be multitasked. If you’re also here, please track me down (or
Quick update: my social media manager and her teammates did indeed capture their second consecutive USA Hockey national championship, so congrats to the whole Shattuck-St. Mary’s crew. She’s off to
With apologies to Inigo Montoya: Let me explain. No, there is too much. Let me sum up: President Biden and Bernie Sanders gave a joint press conference to tout all
An early hockey game means a late-arriving Curve today. There will be more to talk about tomorrow, so I’ll leave the breaking news -- some of which feels like smoke
Another reminder that the quarterly extravaganza of analysis that is Adam Fein’s Drug Channels webinar is kicking off on Friday and focused on the IRA. The full text of this
A quick programming note: first, I’ll be out of position this week, attending the 2024 USA Hockey Tier 1 national championships in support of Reid Strategic’s social media manager. If
The end of this week has Groundhog’s Day vibes to it. Yesterday, I wrote about falling net prices, which is something that I’ve been writing about for years even though
I often act all exasperated when data emerges that shows that the net prices of medicines are going down, feigning frustration at the fact that there has been limited recognition
Merck’s Winrevair won FDA approval yesterday, giving the company the green light to begin selling a medicine that is expected to be a key pillar of the company’s future. The
It’s a big day for PDABs. Buckle up. *** The biggest news is probably Amgen’s suit against the state of Colorado that makes the case that the prescription drug affordability